Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.

Autor: Bhimraj A; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA., Falck-Ytter Y; Department of Medicine, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.; Department of Medicine, VA Northeast Ohio Healthcare System, Cleveland, Ohio, USA., Kim AY; Harvard Medical School, Boston, Massachusetts, USA.; Infectious Diseases Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Li JZ; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Baden LR; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Johnson S; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Shafer RW; Department of Medicine, Stanford University, Palo Alto, California, USA., Shoham S; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tebas P; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bedimo R; Department of Medicine, UT Southwestern/VA North Texas Health Care System, Dallas, Texas, USA., Cheng VC; Department of Microbiology, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China., Chew KW; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Chiotos K; Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia/University of Pennsylvania, Philadelphia, Pennsylvania, USA., Daar ES; Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA., Dzierba AL; Department of Pharmacy, New York-Presbyterian Hospital, New York, New York, USA., Glidden DV; Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA., Hardy EJ; Departments of Medicine and Obstetrics and Gynecology, Brown University, Providence, Rhode Island, USA., Martin GS; Department of Medicine, Emory University, Atlanta, Georgia, USA., MacBrayne C; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA., Nadig N; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Nakamura MM; Antimicrobial Stewardship Program and Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Shumaker AH; Department of Medicine, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.; Department of Medicine, VA Northeast Ohio Healthcare System, Cleveland, Ohio, USA., Tien P; Department of Medicine, UCSF/VA, San Francisco, California, USA., Loveless J; Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America, Arlington, Virginia, USA., Morgan RL; Department of Medicine, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., Gandhi RT; Harvard Medical School, Boston, Massachusetts, USA.; Infectious Diseases Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.

Predicting Neurodegenerative Disease Using Prepathology Gut Microbiota Composition: a Longitudinal Study in Mice Modeling Alzheimer's Disease Pathologies.

Autor: Borsom EM; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Conn K; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Keefe CR; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Herman C; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Orsini GM; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Hirsch AH; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Palma Avila M; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Testo G; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Jaramillo SA; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Bolyen E; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Lee K; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Caporaso JG; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA., Cope EK; Center for Applied Microbiome Sciences, the Pathogen and Microbiome Institute, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA.

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2023 Mar 06, pp. e0345822. Date of Electronic Publication: 2023 Mar 06.

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.

Autor: Bhimraj A; Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA., Morgan RL; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Shumaker AH; VA Northeast Ohio Healthcare System, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Lavergne V; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Baden L; Brigham and Women's Hospital, Boston, Massachusetts, USA., Cheng VC; Department of Microbiology, Queen Mary Hospital, and Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China., Edwards KM; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Gandhi RT; Infectious Diseases Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Gallagher JC; Department of Pharmacy Practice, Temple University, Philadelphia,PennsylvaniaUSA., Muller WJ; Division of Pediatric Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., O'Horo JC; Division of Infectious Diseases, Joint Appointment Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA., Shoham S; Johns Hopkins University School of Medicine, Baltimore, Maryland, USAand., Wollins DS; Infectious Diseases Society of America, Arlington, Virginia, USA., Falck-Ytter Y; VA Northeast Ohio Healthcare System, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 May 03; Vol. 74 (9), pp. 1686-1690.

The public health burden of obstructive sleep apnea.

Autor: Faria A; Universidade Federal de Minas Gerais, Faculdade de Medicina - Pampulha - Belo Horizonte - Brazil., Allen AH; University of British Columbia, Department of Medicine, Faculty of Medicine - Vancouver - British - Columbia - Canada., Fox N; University of British Columbia, Department of Medicine, Faculty of Medicine - Vancouver - British - Columbia - Canada., Ayas N; University of British Columbia, Department of Medicine, Faculty of Medicine - Vancouver - British - Columbia - Canada., Laher I; University of British Columbia, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine - Vancouver - British - 'Columbia - Canada.

Publikováno v: Sleep science (Sao Paulo, Brazil) [Sleep Sci] 2021 Jul-Sep; Vol. 14 (3), pp. 257-265.